Navigation Links
WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
Date:1/16/2008

SHANGHAI, China, Jan. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's leading provider of pharmaceutical R&D outsourcing services is proud to announce today that its Chairman and Chief Executive Officer Dr. Ge Li is named as one of the 2007 China Top 10 Influential Entrepreneurs selected by Entrepreneur China edition.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The 2007 China Top 10 Influential Entrepreneurs selection, organized by Entrepreneur China edition, aims to honor Chinese entrepreneurs who have enabled enormous leaps for their enterprises and whose experiences have prompted profound changes in the Chinese society during the year of 2007. The selection of the winners is based on a comprehensive set of parameters to evaluate the entrepreneur's contribution to revenue growth, employment opportunities, industry impact, public influence and social recognition, capital market performance, wealth creation for employees, as well as social responsibilities. Seeking to exemplify China's most successful entrepreneurs and inspire the new generation to run their own businesses, the organizer selected China's ten most influential business luminaries from over 100 achieved entrepreneurs who brought their companies public in 2007.

Dr. Li has won the award because of his deep understanding of the global pharmaceutical R&D outsourcing market and the successful implementation of his visionary business model and strategy in China. "Under Dr. Li's leadership, WuXi PharmaTech is playing an increasingly important role in the global drug discovery and development industry. This eventually will positively impact China's pharmaceutical industry," according to Entrepreneur.

Founded in 2000, through seven years of rapid development, WuXi PharmaTech has gained trust and confidence from the world's leading pharmaceutical and biotechnol
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
2. WuXi PharmaTech Announces Second Quarter 2007 Results
3. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
4. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
5. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
8. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Aflac Honored with Corporate Citizenship Award
11. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... City, CA (PRWEB) May 20, 2013 ... has announced the appointment of Lisa Baird as Executive ... on July 8, 2013. The WMIS vision ... imaging applications to understand and effectively treat diseases in ... Imaging Society (WMIS) was established in 2011 by integrating ...
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine and ... Albert Einstein College of Medicine and Associate Chairman of ... He is also Associate Director for Clinical Research ... Breast Cancer Working Group, a multidisciplinary group of physicians ... also serves as Vice Chair of the National Cancer ...
(Date:5/17/2013)... Amsterdam, May 17, 2013 - Elsevier, a world-leading provider ... today announced the publication of a recent study in ... old human blastocysts showing that those with an abnormal ... which they have developed to blastocysts, thereby classifying the ... new study the same group has undertaken a retrospective ...
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
Breaking Biology Technology:WMIS Appoints Lisa Baird as Next Executive Director 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... MIGENIX Inc. (the,"Company" or "MIGENIX") (TSX: MGI; ... infectious diseases, reports financial results for the ... a corporate update on its programs,and other ... Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226; topical cationic ...
... decades-old drug to beat atherosclerotic plaques in research conducted ... , The scientists have found that drug-laced nanoparticles plus ... vessels that feed arterial plaques. Their results suggest that ... their growth, which could shrink or stabilize plaques. Although ...
... safe supply of drinking water for regions of the ... is rife. Writing in the International Journal of ... nanotubes could replace conventional materials in water-purification systems. , ... water will continue to grow as major global problems. ...
Cached Biology Technology:MIGENIX Reports First Quarter Fiscal 2009 Financial Results 2MIGENIX Reports First Quarter Fiscal 2009 Financial Results 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 4MIGENIX Reports First Quarter Fiscal 2009 Financial Results 5MIGENIX Reports First Quarter Fiscal 2009 Financial Results 6MIGENIX Reports First Quarter Fiscal 2009 Financial Results 7MIGENIX Reports First Quarter Fiscal 2009 Financial Results 8MIGENIX Reports First Quarter Fiscal 2009 Financial Results 9MIGENIX Reports First Quarter Fiscal 2009 Financial Results 10MIGENIX Reports First Quarter Fiscal 2009 Financial Results 11Old and new therapies combine to tackle atherosclerosis 2Old and new therapies combine to tackle atherosclerosis 3Water purification down the nanotubes 2
(Date:5/16/2013)... The relationship between the heritable risk for schizophrenia ... Schizophrenia is commonly associated with cognitive impairments that ... reduced IQ may be linked to the risk ... may precede the onset of schizophrenia symptoms. Also, ... of people diagnosed with schizophrenia. , In a ...
(Date:5/16/2013)... extinct creature with ,scissor hand-like, claws in fossil records ... movie star. , The 505 million year old ... which is a distant ancestor of lobsters and scorpions, ... starring role as Edward Scissorhands - a movie about ... has scissors for hands. , Kooteninchela deppi ...
(Date:5/16/2013)... genome-wide analysis (GWA), where the entirety of an individual,s ... or variants which can cause health problems is a ... can also pose major ethical problems if used incorrectly, ... Genetics (ESHG) published on line today (16 May 2013) ... Many services based on whole genome and on exome* ...
Breaking Biology News(10 mins):Genetic risk for schizophrenia is connected to reduced IQ 2Actor Johnny Depp immortalized in ancient fossil find 2European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2
... The University of Queensland could contribute to the development ... and Dengue fever. Led by Associate Professor ... of Molecular and Microbial Sciences identified a novel characteristic ... The team found all flaviviruses produced a ...
... to a radical re-thinking about how the snowy owl ... the adult females that we followed in a satellite ... the Arctic sea ice," said Universit Laval doctoral student ... as part of an International Polar Year (IPY) research ...
... LANSING, Mich. --- Research by a Michigan State University ... way of developing protein-based drugs that are key to ... hepatitis. Proteins used in drug manufacture and research ... , a one-cell bacteria. That protein tends to collect ...
Cached Biology News:UQ research targets West Nile virus and dengue fever 2Snowy owl -- a marine species? 2
WD-repeat protein 4...
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
... Cultured human omental preadipocytes ... but otherwise healthy donors. ... of diabetic cells. Please ... Support media also available. ...
ASCIZ...
Biology Products: